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Abstract
Infection with Plasmodium vivax results in strong activation of monocytes, which are important components of both the
systemic inflammatory response and parasite control. The overall goal of this study was to define the role of monocytes
during P. vivax malaria. Here, we demonstrate that P. vivax–infected patients display significant increase in circulating
monocytes, which were defined as CD14+CD162 (classical), CD14+CD16+ (inflammatory), and CD14loCD16+ (patrolling) cells.
While the classical and inflammatory monocytes were found to be the primary source of pro-inflammatory cytokines, the
CD16+ cells, in particular the CD14+CD16+ monocytes, expressed the highest levels of activation markers, which included
chemokine receptors and adhesion molecules. Morphologically, CD14+ were distinguished from CD14lo monocytes by
displaying larger and more active mitochondria. CD14+CD16+ monocytes were more efficient in phagocytizing P. vivax-
infected reticulocytes, which induced them to produce high levels of intracellular TNF-a and reactive oxygen species.
Importantly, antibodies specific for ICAM-1, PECAM-1 or LFA-1 efficiently blocked the phagocytosis of infected reticulocytes
by monocytes. Hence, our results provide key information on the mechanism by which CD14+CD16+ cells control parasite
burden, supporting the hypothesis that they play a role in resistance to P. vivax infection.
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Introduction
Plasmodium vivax is the most widely distributed malaria
parasite and responsible for approximately 70–80 million cases,
annually. In addition, P. vivax is responsible for the majority of
malaria cases and represents a significant impediment to social and
economic development in Latin America and Asia [1]. Both innate
and acquired immunity are thought to play critical role in host
resistance to infection and pathogenesis of malaria [2,3]. However,
the mechanisms by which the innate immune response mediate
resistance to Plasmodium infection or promote a deleterious
systemic inflammation associated with malaria sepsis are poorly
understood [2]. This is particularly true in the case of P. vivax
malaria [4].
The blood is the main tissue affected during P. vivax malaria
since sequestration is not a central event in this infection. When
parasitized reticulocytes rupture in the blood stream, parasite
components are sensed by the innate immune receptors and
activate monocytes [5]. The innate immune system recognizes
Plasmodium sp. through different pattern-recognition receptors
expressed by monocytes and initiates a broad spectrum of defense
mechanisms [6,7,8,9,10]. Importantly, the same immune media-
tors involved in host resistance, such as pro-inflammatory
cytokines are also thought to mediate pathology during acute
malaria episodes [8,11,12]. However, the full spectrum of
monocyte subsets and the specific functions of each monocyte
population during malaria have not been defined.
Besides supplying peripheral tissues with macrophage and
dendritic cell (DC) precursors, monocytes contribute directly to
immune defense against microbial pathogens [13,14,15]. Mono-
cytes were initially identified by their expression of large amounts
of CD14 [16,17]. However, recent studies have revealed that
monocytes in human peripheral blood are heterogeneous and can
be divided into three distinct subsets described based on their
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expression of phenotypic markers. These cells are referred to as,
classical (CD14+CD162 cells), inflammatory or intermediate
(CD14+CD16+) and patrolling (CD14loCD16+) monocytes
[18,19]. Given the importance of monocytes as a major source
of pro-inflammatory cytokines and potential effector cells during
malaria, in this study, we have attempted to define the role of the
various monocyte subsets during P. vivax infection. To address
this question, we phenotypically and functionally characterized the
classical, inflammatory, and patrolling monocytes present in the
peripheral blood from patients experiencing acute malaria
episodes.
We demonstrate that the frequency of circulating monocytes is
elevated during acute infection with P. vivax and that the classical
and inflammatory monocyte subsets are the primary source of pro-
inflammatory cytokines. Importantly, we found that CD16+ cells,
and in particular the CD14+CD16+ LFA-1highICAM-1highPE-
CAM-1high monocytes display augmented effector functions such
as phagocytosis and intracellular reactive oxygen species produc-
tion and are thus likely to be an important cell subset controlling
parasitemia, and mediating host resistance to P. vivax infection.
Methods
Patients
A total of 35 P. vivax-infected patients with uncomplicated
malaria were enrolled in this study at Centro de Pesquisa de
Medicina Tropical de Rondoˆnia (CEPEM) in Porto Velho,
Rondoˆnia, a malaria endemic area in the Amazon region of
Brazil. According to the World Health Organization, uncompli-
cated malaria is a symptomatic infection with malaria parasitemia
without signs of severity and/or evidence of vital organ
dysfunction. Up to 100 ml of peripheral blood was collected
immediately after confirmation of P. vivax infection by thick blood
smear film and again 30–45 days after chemotherapy (n= 35,
ranging from 18 to 66 years old [3569.5]) (Table S1). Additional
36 P. vivax-infected patients were enrolled for reticulocyte
analysis: percentage: mean: 1.383, SD: 0.655; median: 1.150,
IQR: 0.925–1.650; absolute numbers: mean: 51,779, SD: 18,390;
median: 48,100, IQR: 38,970–59,520. Patients were treated for 3
days with chloroquine followed by 7 days with primaquine
according to the Brazilian Ministry of Health. P. vivax infection
and parasitological cure were confirmed by thick blood smear film
and polymerase chain reaction (PCR) [20]. Identification of the
three species of human malaria parasites was done by nested PCR
that targets variant sequences in the small subunit rRNA gene.
The clinical manifestations of acute malaria were fever, myalgia,
chills, arthralgia, nausea, vomiting or diarrhea. Peripheral blood
was also collected from 15 healthy donors (HD) ranging from 21 to
56 years old [3268] living in Porto Velho and negative for P.
vivax infection.
Ethics statement
These studies were performed under protocols reviewed and
approved by the Ethical Committees on Human Experimentation
from Centro de Pesquisa em Medicina Tropical de Rondoˆnia
(CEP-CEPEM 095/2009) and Centro de Pesquisas Rene´ Rachou,
Fundac¸a˜o Oswaldo Cruz (CEP-CPqRR 2004), the National
Ethical Committee (CONEP 15652) from Ministry of Health,
Brazil, as well as by the Institutional Review Board from the
University of Massachusetts Medical school. Only adults, 18 years
old, were enrolled in the study. All patients enrolled in this study
provided written informed consent.
Cellular immunophenotyping
Peripheral blood mononuclear cells (PBMC) were prepared
from heparinized venous blood of adult volunteers by Ficoll-
Hypaque density gradient centrifugation (GE Healthcare Life
Sciences). Cells were stained for surface molecules for 15 minutes
at room temperature. Subsequently, PBMC were washed with
FACS buffer (PBS and 2%FBS), and fixed and permeabilized
according to the manufacture’s instruction (Cytofix/Cytoperm,
BD Biosciences). Cells were then stained for the intracellular
antigens. Cells were finally suspended and maintained in 200 ml of
PBS 2% paraformaldehyde (Sigma Aldrich). At least 100,000-
gated events were acquired for analysis using FACSCan upgraded
with a second laser (5 colors) with Cellquest Pro and Rainbow
from Cytek or LSR II with Diva (both from BD Biosciences). The
antibody panels included the following: anti-CD31 (clone WM59)-
FITC, anti-CD11a (LFA-1) (clone HI111)-FITC, anti-HLA-DR
(clone LN3)-PE, anti-CD14 (clone 61D3)-APC, anti-CD62L (clone
DREG56)-APC, anti-HLA-DR (clone LN3)-efluor 780, anti-
CX3CR1 (clone 2A9-1)-biotin, anti-CD106 (VCAM-1) (clone
STA)-biotin and streptavidin-PE, all purchased from eBioscience;
anti-CD54 (ICAM-1) (clone HA58)-PE, anti-TNF-a (clone
MAb11)-PE, anti-IL-6 (clone MQ2-13A5)-PE, anti-CD197
(CCR7) (clone 3D12)-PECy7 and anti-CD16 (clone 3G8)-
PercPCy5.5, purchased from BD Biosciences; anti-CCR2 (clone
48607)-PE, purchased from R&D Systems. Data were analyzed
using FlowJo Version 9.3.2 (TreeStar). A forward scatter height
(FSC-H) and a side scatter height (SSC-H) gate were used to
initially remove debris and to capture leucocytes. CD14 versus
SSC-H gate was then used to select monocytes. An additional
HLA-DR versus CD16 gate was performed to exclude possible
contamination by neutrophils (CD16+HLA-DR2). A more
detailed analysis of monocyte subpopulations was done based on
CD14 and CD16 expression and here designated as: classical
monocytes (CD14+CD162), inflammatory monocytes
(CD14+CD16+), and patrolling monocytes (CD14luCD16+). The
activation/cell presentation molecule, HLA-DR; the cellular
adhesion molecules, VCAM-1, ICAM-1, PECAM-1, and LFA-1;
the chemokine receptors, CCR2, CX3CR1 and CCR7; and the
cytokine TNF-a was analyzed within CD14+ cells and also within
Author Summary
Malaria, caused by a protozoa parasite, Plasmodium, affects
more than 200 million people per year. The infection
triggers an acute febrile illness, the paroxysms, occurring
every 48 or 72 hours depending on the species. Plasmodium
vivax, in most cases, does not cause severe malaria, but it is
the most geographically widespread parasite responsible
for human disease and causes substantial costs to individ-
uals and governments. Once the parasite reaches the blood
stream, they infect reticulocytes that can be destroyed by
phagocytes. Our goal was to assess the importance of
monocyte subsets during malaria. We found that P. vivax
infection causes an increase in frequency of circulating
monocytes, which were defined as classical, inflammatory,
and patrolling, based on the expression of membrane
molecules. Classical and inflammatory monocytes produced
higher levels of pro-inflammatory cytokines and were
distinguished from patrolling monocytes by displaying
larger and more active mitochondria. Importantly, inflam-
matory monocytes were more efficient phagocytes; pro-
duced high levels of intracellular reactive oxygen species
and TNF and consequently control better Plasmodium vivax
infection. Hence, our results support the hypothesis that
CD14+CD16+ monocytes display effector functions involved
in parasite control during malaria.
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each monocyte subpopulation. Data is shown in frequencies or
mean fluorescence intensity (MFI). In the latter, when graphs are
overlaid, the y-axis is left on automatic scaling and the axis
represents % of Maximum. This normalization is used because
different numbers of events is collected for the monocyte subsets
analyzed and allow us to focus on the important and relevant
variations between the levels of expression of different markers on
the x-axis.
Cytokine measurements
IL-6, IL-8 and IL-10 were measured in cryopreserved plasma
using the Cytometric Bead Array kit (CBA, BD Biosciences
Pharmingen) as recommended by the manufacturer. The concen-
tration of cytokines in each sample was calculated using the BD
FCAP Array Software v 1.0.1 (BD Biosciences).
P. vivax-parasitized reticulocytes enrichment and staining
The red blood cells pellet from the Ficoll-Hypaque (GE
Healthcare Life Sciences) density gradient centrifugation was
harvested and washed three times and then resuspended in RPMI
1640 medium (Sigma Aldrich) to a final hematocrit of 10%. Five
milliliters of this suspension was overlaid on a 5 mL 45% Percoll
solution in a 15 mL tube. After centrifugation, floating mature Pv-
reticulocytes (Pv-Ret) were collected and resuspended in RPMI
1640 [21,22]. The enrichment of Pv-Ret was assessed by optic
microscopy and a purity of 95% was obtained. Where indicated,
enriched Pv-Ret were stained with 1 mM carboxyfluorescein
succinimidyl ester (CFSE) at 16106 cells/mL for 8 minutes at
room temperature before phagocytosis assays (Molecular Probes-
Invitrogen). After stained Pv-Ret were washed three times in
RPMI and 10%FBS.
Expression of NADPH subunits by monocyte subsets
P47phox and p67phox expression was assessed by incubating
PBMC in suspension at 37uC in complete RPMI 1640 supple-
mented with 2 mM glutamine, 10 mM HEPES and 50 mM 2-ME
for 3 hours in medium alone and with P. vivax-Ret (0.5 Pv-Ret/
PBMC) in the presence of 10% immune serum. PBMC were then
washed with FACS buffer, stained for surface molecules for
15 minutes at room temperature, fixed and permeabilized
according to the manufacture’s instruction (Cytofix/Cytoperm,
BD Biosciences).. Cells were then stained for the intracellular
antigens (p47phox and p67phox) for 20 minutes, following
additional 20 minutes incubation with anti-IgG1. After staining,
plates were kept on ice for 15 minutes and cells were harvested
with ice-cold PBS, 2.5 mM EDTA and maintained in 200 ml of
PBS 2% paraformaldehyde. At least 100,000-gated events were
acquired for analysis using a LSRFortessa (BD Biosciences). The
antibody panels included the following: anti-CD16 (clone 3G8)-
Alexa Fluor 700, anti-HLA-DR (Tu39)-FITC, anti-CD14 (clone
M5E2)-APC, purified anti-phox47 (1/p47Phox) and anti-phox67
(D-6), and anti-IgG1 (A851)-PE. The MFI of each monocyte
subpopulation expressing the NADPH subunits was determined
by flow cytometry. Data were analyzed using FlowJo Version X
10.0.7.
Phagocytosis
Phagocytosis was assessed by incubating PBMC in suspension
using 96-wells polystyrene plates at 37uC in complete RPMI 1640
supplemented with 10% heat-inactivated FCS, 2 mM glutamine,
10 mM HEPES, and 50 mM 2-ME for 1, 4 and 12 hours with P.
vivax-Ret previously stained with CFSE (0.5 Pv-Ret/PBMC) in
the absence of immune serum and in the presence of serum or
inactivated serum. In some experiments monoclonal anti-
CD11a (1 mg/mL) (clone G43-25B, BD), anti-CD31 (0.5 mg/
mL) (clone WM59), anti-CD36 (0.5 mg/mL) (clone CB38) and
anti-CD54 (1 mg/mL) (clone HA58) blocking antibodies were
added in the cultures 30 minutes before the addition of P.
vivax-Ret. After staining, plates were kept on ice for 15 minutes
and cells were harvested with ice-cold PBS containing 2.5 mM
EDTA. The frequencies of total monocytes and each monocyte
subpopulation positive for CFSE were determined by flow
cytometry and data were analyzed using FlowJo Version 9.3.2
(TreeStar).
ROS detection
To detect ROS production at the single cell level, the Image-iT
LIVE Green Reactive Oxygen Species Detection kit (Invitrogen)
was used following the manufacturer’s instructions. Briefly, PBMC
were washed twice with PBS and incubated in medium alone or
with Pv-Ret (0.5 Pv-Ret/PBMC) or phorbol 12-myristate 13-
acetate (PMA, 10 ng/mL) and ionomycin (500 ng/mL). Pre-
warmed 25 mM 5-(and-6)-carboxy-29,79-dichlorodihydrofluores-
cein diacetate (carboxy-H2DCFDA) was added to the cells for
3 hours at 37uC. Mitochondrial ROS was assessed by MitoSox red
mitochondrial superoxide indicator (Invitrogen) following the
manufacturer’s instructions. Briefly, PBMC were washed twice
with HBSS and incubated in medium alone or with Pv-Ret (0.5
Pv-Ret/PBMC) or PMA (10 ng/mL) and ionomycin (500 ng/mL)
and 10 mm MitoSox. After 30 minutes incubation, monoclonal
antibodies against CD14 and CD16 were added to cell cultures to
allow monocyte subpopulations analysis. Cell suspension was
washed after additional 30 minutes incubation with HBSS at
37uC. Plates were kept on ice for 15 minutes and cells were
harvested with ice-cold PBS containing 2.5 mM EDTA. Cells
were acquired by flow cytometry and data were analyzed using
FlowJo Version 9.3.2.
Purification of monocyte subpopulations
After PBMC preparation CD14+CD162, CD14+CD16+ and
CD14loCD16+ monocytes from HD and P. vivax-infected patients
were sorted with a FACSAria II cell sorter (BD Biosciences), using
the combination of antibodies described above. CD14+CD162,
CD14+CD16+ and CD14luCD16+ monocytes were then collected
and fixed with 2.5% buffered glutaraldehyde solution, 0.1 M, for
electron microscopy or with RLT buffer (QIAGEN) supplemented
with b-mercaptoethanol for mRNA detection and nanostring
analysis as described below.
Electron microscopy
After FACS-sorting, cells were prepared as previously described
[23,24]. Briefly, cells were fixed in 2.5% buffered glutaraldehyde
solution, 0.1 M, pH 7.2, 6 h, 8uC. Cells were then washed with
the same buffer. The pellets were included in phosphate buffer,
4% agarose and left overnight at 4uC. Next, the cells were fixed in
a mixture of 1% osmium tetroxide and 1.5% (w/v) potassium
ferrocyanide, dehydrated in a graded series of ethanol solutions,
infiltrated, and embedded in Araldite 502 (Electron Microscopy
Sciences, Hatfield, PA, USA). After polymerization, thin sections
were obtained using a diamond knife on a Sorvall MT-2B
ultramicrotome (Dupont, Wilmington, DE, USA) and mounted on
uncoated 200-mesh copper grids (Ted Pella, Inc., Redding, CA,
USA). Sections were stained with 2% uranyl acetate and Reynolds
lead citrate and then analyzed using transmission electron
microscopy (EM 10A Zeiss).
Monocyte Subsets in Malaria
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mRNA detection
mRNA was assessed by nanostring analysis [25]. nCounter
CodeSets were constructed for detecting selected human-specific
genes. A total of 16104 cells of each subset were lysed in RLT
buffer (QIAGEN) supplemented with b-mercaptoethanol. This
lysate was mixed with capture and reporter probes, hybridized to
the Codeset for 16 hr and loaded onto the nCounter prep station,
and then quantified with the nCounter Digital Analyzer. For side-
by-side comparisons of nCounter experiments, data were normal-
ized in two ways described previously [26]. Briefly, the first
normalization was for small variations utilizing the internal
positive controls that are present in each CodeSet. Then the
samples were normalized with 7 housekeeping genes that were
included in the CodeSet. The data was analyzed with n Solver
software. The heatmap was constructed using log2 transformed
data and the Tiger Multi Experiment Viewer software.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
software, version 5.0. The results were analyzed using two-tailed
paired t-test. Wilcoxon testing was used when data did not fit a
Gaussian distribution. The results were analyzed using unpaired t-
test when two groups were compared. Mann-Whitney (MW) test
was used when a normality test failed. Analyses were also done
between HD (represented in the graphs as dashed line) and
patients after cure and no significant differences were found. The
correlation analyses were performed using the Spearman’s rank.
Differences were considered to be statistically significant, when p#
0.05.
Results
P. vivax-infected patients display higher levels of plasma
cytokines accompanied by increased frequencies of
circulating monocytes
High levels of the pro-inflammatory cytokines, IL-6 and IL-8,
and regulatory cytokine IL-10, were found in the circulation of P.
vivax-infected patients before treatment initiation, when com-
pared to the same patients after anti-malarial therapy (Figure 1A).
While the cytokinemia of P. vivax-infected patients was signifi-
cantly higher than individuals after cure, the absolute numbers of
total leukocytes decreased with infection (Figure 1B). The
frequencies of lymphocytes were lower, whereas the proportions
of polymorphonuclear cells and monocytes were higher in
symptomatic malaria patients. Monocyte frequencies were also
assessed within PBMC by flow cytometry. The frequencies of
CD14+ monocytes were significantly higher in P. vivax-infected
patients than in the same individuals after treatment (Figure 1C).
P. vivax infection alters the expression of HLA-DR,
adhesion molecules and chemokine receptors on
circulating monocytes
The expression of the activation marker, HLA-DR, cell
adhesion molecules, CD54, CD106, CD31, and chemokine
receptors, CXCR3, CCR7, was analyzed on circulating mono-
cytes (Figure 2). Significantly lower levels of HLA-DR were found
on monocytes from P. vivax-infected patients when compared to
the same patients after treatment (Figure 2). Monocytes from
acute malaria patients also displayed significantly lower levels of
the adhesion molecule CD31 and the chemokine receptor CCR7
(Figure 2). In contrast, significantly higher expression of the
adhesion molecules CD106 (VCAM-1), CD54 (ICAM-1), and the
chemokine receptor CX3CR1, were observed on monocytes from
acute malaria patients before treatment initiation (Figure 2). The
expression of all these molecules on monocytes from malaria
patients reached the levels found in healthy donors when analyzed
30 days after treatment. Thus, monocytes from P. vivax-infected
patients exhibit a distinct activation state during acute infection.
Monocyte subpopulations from P. vivax-infected patients
display distinct activated phenotypes
As noted above, human monocyte subsets can be distinguished
by flow cytometry based on the expression of CD14 and CD16
[18]. The majority of monocytes express CD14 but not CD16, and
those expressing CD16 can be subdivided into two subpopulations,
CD14+CD16+ and CD14loCD16+ cells (Figure 3A). They are also
slightly different in granularity as previously described and shown
in Figure S1 [18]. To exclude any contaminating neutrophils, only
HLA-DR+ cells were included in the analysis and CD16+ cells
were included only if they also expressed HLA-DR. Higher
frequencies of CD14+CD162 monocytes were found in P. vivax-
infected patients when compared with patients after treatment
(Figure 3B). The frequencies of CD14+CD16+ and CD14loCD16+
monocytes did not differ significantly between malaria patients
before and after treatment.
Chemokine receptors and the adhesion molecule, LFA-1, have
been reported to be differently expressed on monocyte subsets.
Previous studies described that CCR2 is expressed by both
CD14+CD162 and CD14+CD16+ but not by CD14loCD16+
monocytes [18,27]. Similarly in P. vivax-infected patients, low
levels of CCR2 were found in CD14+CD162 and CD14+CD16+
monocytes and, as expected, CCR2 was barely expressed by
CD14loCD16+ cells (Figure 3C and 3D). In addition, no changes
in LFA-1 expression in the different monocyte subsets were
observed in P. vivax patients as a result of treatment (Figure 3C).
Higher LFA-1 levels were observed in CD14+CD16+, followed by
CD14loCD16+ and CD14+CD162 monocytes (Figure 3D). The
expression of CX3CR1 along with LFA-1 has been implicated in
the ability of CD14loCD16+ monocytes to crawl on the inner
surface endothelium of blood vessels [18,28]. Importantly, P.
vivax infection triggered a significantly increased expression of
CX3CR1 on CD14+CD162, CD14+CD16+ and CD14loCD16+
monocytes (Figure 3C). CX3CR1 was expressed at lower levels by
CD14+CD162 monocytes, when compared to the CD16+
populations (Figure 3D). Lastly, changes in CCR7 expression
were observed only on CD14+CD162 monocytes, with those from
P. vivax infected patients expressing lower levels of CCR7
compared to monocytes from treated individuals (Figure 3C).
Thus, all the monocyte subpopulations from P. vivax-infected
display a distinct phenotypic profile in patients undergoing acute
malaria compared with the same individuals after treatment.
P. vivax induces a variety of inflammatory genes during
malaria infection
We next FACS-sorted the CD14+CD162, CD14+CD16+ and
CD14loCD16+ monocyte subpopulations from healthy donors and
P. vivax-infected patients (Figure 4A). The purity of each cell
population is shown in Figure 4A. Since the numbers of each
circulating monocyte subset obtained from the FACS-sort was
limited, we chose to assess the expression of several genes involved
in inflammatory responses by nanostring [25]. The expression of
72 selected genes involved in innate immune response, cell
adhesion, migration and phagocytosis was evaluated, and we
found that 41 genes had their expression significantly altered in at
least one of the monocyte subpopulations upon P. vivax infection
(Figure 4B). Differences greater than 4-fold cannot be appreciated
Monocyte Subsets in Malaria
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Figure 1. P. vivax-infected patients display higher levels of cytokines accompanied by increased frequencies of circulating
monocytes. (A) IL-6, IL-8 and IL-10 were measured in plasma of P. vivax-infected individuals before (BT, black circles) and 30–45 days after (AT, grey
circles) treatment (n = 20). Levels of cytokine were measured by Cytometric Bead Array. (B) Leukocyte counts and frequencies from P. vivax-infected
individuals before (BT, black circles) and after (AT, grey circles) treatment were assessed at a clinical laboratory (n = 33). C) Representative density plots
of CD14+ monocytes (left panel) and frequencies of CD14+ monocytes (right panel) within PBMCs from P. vivax-infected individuals (BT, n = 28 and AT,
n = 20). Circles indicate individual patients and lines represent median values and interquartile ranges. Dotted lines represent medians of a given
measurements from healthy donors. *p,0.05, ***p,0.01.
doi:10.1371/journal.ppat.1004393.g001
Monocyte Subsets in Malaria
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in the heatmap, once the range from 24.0 to +4.0 fold was
selected to better reveal differences in the majority of the genes
induced by malarial infection in monocyte subsets. Once changes
in gene expression were detected upon P. vivax infection, the
expression of each of these genes was compared among the
monocytes subset from P. vivax-infected patients (Figure 4C). In
general, the CD14+ subpopulations, i.e., the classical and
inflammatory monocytes, expressed higher levels of RNAs
encoded by pro-inflammatory genes. The chemokines CCL2
and CXCL2 were highly expressed by CD14+CD162 and
CD14+CD16+ subpopulations, but were expressed at lower levels
by CD14loCD16+ monocytes (Figure 4C). The same pattern of
expression was observed for TNFR1/TNFRSF1A and ICAM-1
with CD14+CD162 and CD14+CD16+ expressing higher levels
than CD14loCD16+ monocytes (Figure 4C). The classical mono-
cytes, CD14+CD162 expressed higher counts of mRNA for the
receptor for IFN-gamma and for the IL-1 receptor agonist IL-1RA
(Figure 4C). The expression of cytokine genes also varied among
monocyte subsets. Both IL6 and IL10 had higher expression in
CD14+CD16+ compared to CD14+CD162 cells. CD14loCD16+
monocytes expressed higher levels of mRNA for TNF and lower
levels of IL8 than the CD14+CD162 subset. CD14+CD162 as
well as CD14+CD16+ monocytes expressed higher amounts of
NLRP3 and CASPASE1 than patrolling monocytes. The same
Figure 2. P. vivax infection alters the expression of activation markers, adhesion molecules and chemokine receptors on circulating
monocytes. Mean fluorescence intensity (MFI) of HLA-DR (BT, n = 24 and AT, n = 19), CD31 (BT, n = 25 and AT, n = 20), CCR7 (BT, n = 28 and AT, n = 19)
(left panels, from the top to the bottom), CD54 (BT, n = 25 and AT, n = 19), CD106 (BT, n = 28 and AT, n = 19), CX3CR1 (BT, n = 28 and AT, n = 20) (right
panels, from the top to the bottom) was evaluated on monocytes from P. vivax-infected subjects, before (BT, black circles) and 30–45 days after
treatment (AT, grey circles). Circles indicate individual patients and lines represent median values and interquartile ranges. Dotted lines represent
medians of a given measurements from healthy donors. Levels of the molecules above were measured by flow cytometry. **0.05.p.0.01, *** p,
0.01.
doi:10.1371/journal.ppat.1004393.g002
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Figure 3. Characterization of monocyte subsets in malaria patients. (A) Representative dot plots showing the gate strategy for the
identification of CD14+CD162 (green gate), CD14+CD16+ (red gate), CD14loCD16+ (blue gate) monocyte subsets. CD14+CD162, CD14+CD16+ and
CD14loCD16+ monocytes are represented by green, red and blue symbols. (B) Frequencies of CD14+CD162, CD14+CD16+ and CD14lo monocytes
within PBMC from P. vivax-infected patients before (BT, filled symbols) and 30–45 days after treatment (AT, open symbols) (n = 28). (C) Mean
fluorescence intensity (MFI) of CCR2 (BT, n = 28 and AT, n = 18), CX3CR1 (BT, n = 26 and AT, n = 19), CCR7 (BT, n = 28 and AT, n = 19) and LFA-1 (BT,
n = 15 and AT, n = 11) (from the top to the bottom) was evaluated on monocyte subsets (CD14+CD162 (left panel), CD14+CD16+ (middle panel),
CD14loCD16+ (right panel)) from P. vivax-infected subjects, before and 30–45 days after treatment. Dotted lines represent medians of a given
measurements from healthy donors. (D) Scattered dot plots (left panels) and representative histograms (right panels) showing MFI of the molecules
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pattern of expression was observed for NFKB1 and NFKB1A,
involved respectively with induction and regulation of cytokine
expression, with CD14+CD162 and CD14+CD16+ expressing
higher levels than CD14loCD16+ monocytes. REL that encodes a
protein that is a member of the Rel/NFKB family was more highly
expressed on CD14+CD16+ monocytes than on the other
monocyte subpopulations. The expression of the costimulatory
molecule CD80 was higher in CD14+CD16+ than classical and
patrolling monocytes (Figure 4C). Together these data indicate
that CD14+CD162 and CD14+CD16+ monocytes have a more
activated and inflammatory profile than patrolling monocytes
during malaria.
Monocytes from P. vivax infected patients exhibit
morphologic changes
Patrolling monocytes can be distinguished from the classical and
inflammatory subsets based on size and granularity [18], but no
ultrastructural analysis had been previously performed on these
cell subpopulations. Electronic microscopy was performed at-
tempting to reveal morphological changes suggestive of functional
alterations. FACS-sorted CD14+CD162, CD14+CD16+ and
CD14loCD16+ monocytes from healthy donors (n = 5) and P.
vivax-infected patients (n = 6) (Figure 4A) were fixed and pro-
cessed for ultrastructural analysis by electron microscopy (Fig-
ure 5A). CD14+CD162 and CD14+CD16+ monocytes from HD
(Figure 5A, upper panel) and P. vivax-infected patients (Fig-
ure 5A, lower panel) had a larger and a higher number of
mitochondria (white arrows) when compared to CD14loCD16+
monocytes. All monocyte subsets from P. vivax-infected patients
displayed morphological features compatible with activation
(Figure 5A). Moreover, mitochondria from CD14+CD16+ cells
from P. vivax-infected patients were significantly larger than those
in the two other monocyte subsets, when mitochondria area was
measured using the software ImageJ 1.47K (NIH) (Figure 5B).
Mitochondria area was assessed in at least six cells of each
monocyte subpopulation per patient.
ROS are generated in multiple compartments and by multiple
enzymes in the cell and important contributions include proteins
within the plasma membrane, e.g., NADPH oxidases, and
mitochondria [29,30]. Since mitochondria are at least in part
responsible for the generation of ROS [31,32], we further assessed
the content of mitochondria in the monocyte subsets from P.
vivax-infected patients. MitoTracker Red CMX-Ros was used for
this propose. The MFI of MitoTracker Red, probe sensitive
to membrane potential, was assessed in CD14+CD162,
CD14+CD16+ and CD14loCD16+ monocyte subsets by flow
cytometry (Figure 5C). CD14+CD162 and CD14loCD16+ mono-
cytes similarly react with Mitotracker Red while significantly
higher reactivity was found in CD14+CD16+ monocytes (Fig-
ure 5C). Our data show that CD14+CD16+ monocytes have larger
and more active mitochondria suggesting differential metabolic
activity during P. vivax infection. The expression of p47phox and
p67phox, cytosolic components of the NADPH oxidase, was also
measured in monocyte subsets from malaria patients after a short-
term culture with P. vivax-infected reticulocytes. Higher expres-
sion of p47phox and p67phox were found in CD14+CD16+
monocytes when comparing to their other counterparts
(Figure 5D).
Monocyte subpopulations from malaria patients display
distinct levels of molecules involved in cell activation and
migration
Upon activation monocytes undergo several changes, including
expression of molecules involved with antigen presentation, cell
adhesion and migration [33,34,35]. CD14+CD162 monocytes
from patients undergoing P. vivax infection expressed lower levels
of HLA-DR (Figure 6A). In contrast, the expression of HLA-DR
did not differ in CD14+CD16+ and CD14loCD16+ monocytes
when cells from malaria patients were compared before and after
treatment (Figure 6A). Higher levels of HLA-DR were found in
CD14+CD16+ monocytes compared to their other counterparts
during P. vivax infection (Figure 6A, B, C).
We also observed that P. vivax infection triggered the
expression of VCAM-1 and ICAM-1 in all three monocyte
subpopulations (Figure 6). In contrast, a decreased expression of
PECAM-1 was observed in patients experiencing malaria when
compared to the same patients after treatment (Figure 6A).
Importantly, CD14+CD16+ monocytes from P. vivax-infected
patients expressed the highest levels of ICAM-1 and PECAM-1,
when compared to CD14+CD162 and CD14loCD16+ monocytes
(Figure 6B, C). Taken together these results further corroborate
that CD14+ monocytes, especially the CD14+CD16+ subset, are
highly activated during P. vivax malaria.
CD16+CD14+ monocytes display elevated phagocytosis
We used CFSE labeled P. vivax-infected reticulocytes (Pv-Ret)
to quantify phagocytosis by different monocyte subpopulations
from malaria patients before treatment initiation. CD14+CD16+
cells displayed significantly higher levels of phagocytosis of Pv-Ret
than the other monocyte subsets (Figure 7A). The phagocytic
ability of CD14+CD16+ cells was followed by the CD14loCD16+
patrolling monocytes, which was significantly better than the
CD14+CD162 monocytes (Figure 7A). It is important to note that
significant differences are found in the phagocytic ability of
monocyte subsets when uninfected reticulocytes are purified from
healthy donors and co-cultured with PBMC from patients and
healthy donors. Much lower frequencies of reticulocytes contain-
ing monocytes are detected when cultures are performed with
uninfected reticulocytes compared to P. vivax-infected reticulo-
cytes (CD14+CD162: 3.54%60.52% vs. 71.14%611.11%,
CD14+CD16+: 23.20%62.18% vs. 98.33%61.40%,
CD14loCD16+: 23.18%64.22% vs. 87.13%68.10%). The same
phenomenon was shown for P. falciparum [36].
Interestingly, higher levels of phagocytosis of Pv-Ret correlated
with higher expression of the adhesion molecules ICAM-1 (CD54),
LFA-1 (CD11a) and PECAM-1 (CD31) by monocytes (Figure 7B).
As adhesion molecules, such as CD54, expressed by cell lines
interact with P. vivax-infected reticulocytes [22], we used blocking
antibodies to assess whether phagocytosis of P. vivax-infected
erythrocytes was dependent on those interactions. Indeed, the
phagocytosis of Pv-Ret by CD14+ cells was partially blocked by
either anti-CD54 or -CD11a or -CD31, as observed by the
significantly decreased frequencies of monocytes containing Pv-
Ret (Figure 7C). To assess the ability of each monocyte
subpopulation to kill Pv-Ret, PBMC were left in cultures for
12 h in the presence of CFSE-labeled-Pv-Ret, and the mean
fluorescence intensity of CFSE were measured in each monocyte
described above on CD14+CD162, CD14+CD16+ and CD14loCD16+ monocytes from P. vivax-infected patients before treatment (open histograms).
Levels of the molecules above were measured by flow cytometry. Circles indicate individual patients and lines represent median values and
interquartile ranges. (E) Levels of molecules expressed by the monocyte subsets analyzed according to D. * p,0.05, **0.05.p.0.01, ***p,0.01.
doi:10.1371/journal.ppat.1004393.g003
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subset. The MFI of CFSE was only decreased in CD14+CD16+
monocytes when analyzed 12 h and compared to 4 h of culture
(Figure 7D). Both CD14+CD162 and CD14luCD16+ displayed
similar levels of Pv-Ret containing monocytes when the MFI was
compare between 4 and 12 h of culture. Important to mention
that no significant increase in apoptosis or changes in the
Figure 4. Monocyte subsets display distinct gene expression. CD14+CD162, CD14+CD16+ and CD14loCD16+ monocytes from healthy donors
and P. vivax-infected patients were isolated by FACS. (A) Representative dot plots showing monocyte subpopulations before (left panel) and after
FACS-sorting (right panels). (B) A nanostring analysis of monocyte subsets from 5 patients infected with P. vivax and 5 healthy donors. Heatmap
representation of 41 differentially regulated genes upon malaria infection compared to healthy donors is depicted. (C) CCL2, CXCL2, ICAM1, NLRP3,
TNFR1/TNFRSF1A, NFKB1, REL, NFKB1A, IFNGR2, IL1RA, IL8, CASP1, CR1, CD80, IL10, IL6 and TNF were differentially induced among CD14+CD162 (green
bars), CD14+CD16+ (red bars) and CD14loCD16+ (blue bars) monocytes from P. vivax-infected patients. *p,0.05, **0.05.p.0.01, ***p,0.01.
doi:10.1371/journal.ppat.1004393.g004
Figure 5. Circulating monocyte subpopulations display distinct morphology, mitochondrial and NADPH subunit content. FACS-
sorted CD14+CD162, CD14+CD16+ and CD14loCD16+ monocytes from healthy donors and P. vivax-infected patients were fixed and prepared for
electron microscopy. Monocyte subsets from a single healthy donor (A, upper panel) and a single patient (A, lower panel) shown are representative of
the analysis of at least six cells of each monocyte subpopulation per patient and of the analysis of 5 controls and 6 patients. Mitochondria (white
arrows) and vesicles (black arrows). Scale bar, 2 mm. (B) Mitochondria area from CD14+CD162 (green circles), CD14+CD16+ (red circles) and
CD14loCD16+ (blue circles) monocytes was assessed using ImageJ. Circles indicate individual mitochondria. (C) Mitochondria content in CD14+CD162
(green bars), CD14+CD16+ (red bars) and CD14loCD16+ (blue bars) monocytes from P. vivax-infected patients was measured based on Mitotracker
reactivity (n = 11). (D) Mean fluorescence intensity (MFI) of p47phox and p67phox within CD14+CD162, CD14+CD16+, CD14loCD16+ monocytes from P.
vivax-infected patients was measured by flow cytometry 3 hours after culture in medium alone or P. vivax-infected reticulocytes (n = 4). Results are
representative of 2 independent experiments. Symbols represent individual subject. *p,0.05, ***p,0.01.
doi:10.1371/journal.ppat.1004393.g005
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proportions of monocyte subsets were detected when PBMC were
cultured for 4 and 12 hours in medium or Pv-Ret (Figure S2) (Text
S1).
Higher levels of intracellular TNF and ROS are found in
CD14+CD16+ monocytes compared to their other
counterparts
To examine the mechanism of killing, we evaluated the ability
of the different monocytes to produce TNF-a and ROS, which are
key effector molecules made by activated monocyte/macrophages.
Significantly higher frequencies of TNF-a producing cells were
found among CD14+CD16+ monocytes when PBMC were
cultured with Pv-Ret (or LPS) (Figure 7E).
ROS production by PBMC and monocyte subsets from P.
vivax-infected patients was measured by luminescence (RLU) of
luminol or fluorescence (RFU) of H2DCFDA (Figure S4). PBMC
from P. vivax-infected patients produced detectable amounts of
total ROS spontaneously or in response to PMA, when measured
by luminol (Figure S4A) (Text S1). PBMC from acutely infected
patients produce higher levels of ROS than the same patients after
treatment. In addition, total ROS production was measured in
purified monocyte subsets, but no significant differences were
found among them (Figure S4B). Intracellular ROS production by
each monocyte subpopulation was also measured in the single-cell
level by flow cytometry. Consistent with the phagocytosis and
TNF-a results, CD14+CD16+ monocytes exposed to Pv-Ret
Figure 6. Monocyte subsets from P. vivax-infected patients display a highly activated phenotype. CD14+CD162, CD14+CD16+ and
CD14loCD16+ monocytes are represented by green, red and blue symbols. (A) Mean fluorescence intensity (MFI) of HLA-DR (BT, n = 11 and AT, n = 11),
CD106 (BT, n = 26 and AT, n = 19), CD54 (BT, n = 28 and AT, n = 19) and CD31 (BT, n = 25 and AT, n = 20) (from the top to the bottom) was evaluated on
monocyte subsets (CD14+CD162 (left panel), CD14+CD16+ (middle panel), CD14loCD16+ (right panel)) from P. vivax-infected subjects, before (filled
symbols) and 30–45 days after treatment (open symbols). Dotted lines represent medians of given measurements from healthy donors. (B) Scattered
dot plots (left panels) and representative histograms (right panels) showing MFI of the molecules described above on CD14+CD162, CD14+CD16+ and
CD14loCD16+ monocytes from P. vivax-infected patients before treatment. Levels of the molecules above were measured by flow cytometry. Circles
indicate individual patients and lines represent median values and interquartile ranges. (C) Levels of molecules expressed by the monocyte subsets
analyzed according to B. *p,0.05, **0.05.p.0.01, ***p,0.01.
doi:10.1371/journal.ppat.1004393.g006
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generated significantly higher levels of ROS than the other
monocyte subpopulations (Figure 7F).
We then performed experiments using rotenone and DPI
(diphenylene iodonium) to block respectively the mitochondria
complex I and NADPH oxidase plus nitric oxide synthases
[37,38,39]. The inhibition of ROS production was assessed in
PBMC by luminescence using luminol and in monocyte subsets
using H2DCFDA by flow cytomety (Figure S4C and S4D).
Rotenone was able to partially inhibit ROS production by PBMC
(Figure S4C) and by CD14+CD16+ cells cultured with parasitized
reticulocytes (Figure S4D). When DPI was added in the culture, it
was able to abrogated ROS production by PBMC (Figure S4C).
Partial inhibition was observed when H2DCFDA
+CD14+CD16+
cells from malaria patients were cultured with Pv-Ret and
assessed by flow cytometry (Figure S4D). To more specifically
analyze whether mitochondrial ROS were differentially pro-
duced by monocyte subsets during malaria, MitoSox staining
was performed. Corroborating with total intracellular ROS
production assessed with H2DCFDA, CD14
+CD16+ cells
were the monocyte subset that most reacted with MitoSox
(Figure 7G).
Taken together, our data indicate that CD14+CD16+ inflam-
matory monocytes play important effector activity during P. vivax
infection.
Figure 7. CD16+CD14+ monocytes display pronounced phagocytic ability than other subsets. CD14+CD162, CD14+CD16+ and
CD14loCD16+ monocytes are represented by green, red, and blue symbols, respectively. P. vivax-infected reticulocytes (Pv-Ret) were purified, CFSE
labeled (A, B, C) or not (D, E) and cultured with PBMC from acutely P. vivax-infected subjects. (A) Mean fluorescence intensity (MFI) of CFSE within
CD14+CD162, CD14+CD16+, CD14loCD16+ monocytes exposed to P. vivax was measured by flow cytometry after 4 hours of culture. Each circle
represents a single patient (n = 12) and lines represent median values and interquartile ranges (B) Correlation between P. vivax phagocytosis (CFSE
MFI) and CD54, CD11a or CD31 expression by CD14+CD162, CD14+CD16+, CD14loCD16+ monocytes. Circles indicate individual patients (n = 13). (C)
Phagocytosis of Pv-Ret by CD14+ cells was measured in the absence of serum, presence of inactivated serum and presence of serum, and in the
presence of anti-CD54, CD11a and CD31 blocking antibodies (lower graph). Bars represent median values and interquartile ranges (n = 6). (D) MFI of
CFSE within CD14+CD162, CD14+CD16+, CD14loCD16+ monocytes exposed to P. vivax was measured by flow cytometry after 4 and 12 hours of
culture. Connecting circles represent values of CFSE MFI of a single patient after 4 and 12 hours of culture, (n = 12) (E) Frequencies of TNF-a
producing monocyte subsets were measured after culture with medium alone, Pv-Ret or LPS. Bars represent median values and interquartile ranges
(n = 6). (F) ROS production was detected by measuring MFI (top panel) and the proportions (middle panel) of carboxy-H2DCDA
+ CD14+CD162,
CD14+CD16+ and CD14loCD16+ monocytes after 3 hours incubation with P. vivax-infected reticulocytes. Bars represent median values and
interquartile ranges (n = 9). Representative histograms showing MFI of carboxy-H2DCFDA expressing CD14
+CD162, CD14+CD16+, CD14loCD16+
monocytes (bottom panel). Grey histogram represents CD14+ cells cultured in the absence of Pv-Ret. (G) Mitochondrial ROS was assessed in
monocyte subsets from P. vivax-infected patients measuring MitoSox by flow cytomery after culture with P. vivax-infected reticulocytes (n = 4).
Connecting circles represent frequencies of different monocyte subsets producing mitochondrial ROS. Symbols represent individual subject.
Representative histograms showing MFI of MitoSox expressing CD14+CD162, CD14+CD16+, CD14loCD16+ monocytes (bottom panel). Grey histogram
represents MitoSox- cells. *p,0.05, **0.05.p.0.01, ***p,0.01.
doi:10.1371/journal.ppat.1004393.g007
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Discussion
Although pro-inflammatory cytokines play an important role in
host resistance to Plasmodium infection, various studies reported
that they may contribute to deleterious effects during malaria
[40,41,42]. Thus, the pathways involved on induction of these
mediators during malaria, represent checkpoints for immunolog-
ical intervention to prevent poor outcome of disease. Monocytes
have been described as a major source of cytokines during P. vivax
infection [5]. Although infection with Plasmodium spp is known to
dramatically alter monocyte differentiation [43], the role of
monocyte subsets in host resistance to infection and pathogenesis
of malaria remains poorly understood. The findings reported here
clearly demonstrate that both the classical (CD14+CD162) and
intermediate or inflammatory (CD14+CD16+) monocytes are
important sources of cytokines during acute P. vivax infection.
Intriguingly, the CD14+CD16+ cells displayed the highest
mitochondria content and activity, being an important source of
ROS and were the most efficient phagocytes of P. vivax infected
reticulocytes.
Both in mice and human, different monocyte subsets seem to
reflect developmental stages with distinct physiological roles, such
as recruitment to inflammatory lesions or entry to normal tissues
[17]. Consistent with our results assessing the monocyte subsets in
P. vivax-infected patients, the majority of monocytes found in
steady state, known as classical monocytes, express CD14 but not
CD16, and the remaining monocytes express both CD14 and
CD16: CD14+CD16+ (inflammatory) and CD14loCD16+ (patrol-
ling) monocytes [18]. This classification still gives rise to discussion.
Ziegler-Heitbrock and coworkers has defined CD14loCD16+ as
non-classical and CD14+CD16+ as intermediate monocytes [44].
Moreover, some studies have been analyzed monocytes based on
the expression of molecules related to differentiation/activation
found in macrophages [45,46]. Despite several of these molecules
were assessed in this study many others, such as CD68, CD163
and CD206 have been strongly correlated with different monocyte
subsets [45].
As described here, both classical and inflammatory monocytes
expressed the chemokine receptor CCR2. It was previously shown
in the P. chabaudi rodent model of malaria that inflammatory
monocytes migrate to spleens, in CCR2 dependent manner, where
they are important effector cells implicated in the control of
parasite burden, likely through their phagocytic activity and
release of ROS [47]. CCR2, the chemokine receptor for CCL2
(also known as monocyte chemotactic protein-1) is a marker for
inflammatory monocytes. These monocyte subsets were also
shown to express higher levels of mRNA encoding CCL2 when
compared to the patrolling monocytes. Similarly, a previous study
reported that patients infected with either P. vivax or P.
falciparum have high levels of circulating CCL2 [48]. Classical
and inflammatory monocytes from P. vivax-infected patients also
expressed high levels of inflammatory mediators, including
CXCL2 and the receptors for TNF-a, IFN-c and IL-1. Despite
the similarities described above, CD14+CD16+ monocytes dis-
played the highest frequencies of TNF-a producing cells when
exposed to Pv-Ret. Interestingly, CD14+CD16+ monocytes also
expressed higher mRNA for IL-10 than the other monocyte
subsets. It has been described that highly activated effector cells
can acquire regulatory features. During Leishmania [49,50], T.
cruzi [51] and T. gondii [52] infection polarized Th1 cells produce
IL-10 along to IFN-c, in attempt to control immunopathology.
The same has been described for monocytes. A recent article
shows in the murine model of toxoplasmosis that Ly6Chi
monocytes entering the gastrointestinal tract responded to
commensal ligands by adopting a regulatory phenotype. For
instance inflammatory monocytes became capable to control
parasite burden while limiting collateral damage to tissue [53].
Indeed, plasma levels of IL-10 are lower with increased disease
severity during P. vivax infection [42]. Thus, the expression of this
counter regulatory cytokine may also represent an important role
of CD14+CD16+ monocytes in preventing immunopathology
during P. vivax malaria.
Different adhesion molecules, including CD36, ICAM-1,
VCAM-1 and PECAM-1 have been described as important
receptors that bind P. falciparum infected red blood cells and
influence the outcome of disease [54,55]. P. falciparum-infected
erythrocytes are able to tether and roll on CD36, ICAM-1, P-
selectin, and VCAM-1 in a shear-dependent fashion. In addition,
CD36 has an important role in phagocytosis of P. falciparum
infected cells [56,57,58]. On the other hand, ICAM-1, but not
CD36, was implicated in the cythoadhesion of P. vivax to
endothelium cells [22]. We found that CD14+CD16+CCR2+
inflammatory monocytes from P. vivax malaria patients express
the highest levels of ICAM-1, PECAM-1, and LFA-1. Although
these adhesion molecules were originally identified as endothelium
receptors for parasitized red blood cells, their expression on
monocytes may favor biding and uptake of P. vivax infected
reticulocytes. Indeed, our results indicate that the phagocytic
activity of different monocyte subsets positively correlated with the
expression of ICAM-1, PECAM-1 and LFA-1 and blockade of
each of these adhesion molecules efficiently inhibited phagocytosis
of Pv-Ret.
It is noteworthy that CD14+CD16+ monocytes have also been
reported to expand in a group of P. falciparum-infected patients,
and total monocytes from these patients were able to better control
parasite growth in vitro, through antibody dependent cellular
inhibition [59,60]. CD16, a Fcc receptor, has a high affinity for
IgG1 and IgG3 [61] and therefore may be involved in
phagocytosis of Plasmodium infected red blood cells. In contrast,
experiments performed with Staphylococcus aureus or Echerichia
coli showed that CD14+ monocytes have higher phagocytic
activity than CD14lo monocytes. However no differences were
observed between CD14+CD16+ and CD14+CD162 monocytes
[62]. In our system, the expression of CD16 was not the only
molecule involved in phagocytosis since the ability of Pv-Ret
internalization was different between CD14+ and CD14lo, both
expressing CD16. The expression of adhesion molecules ICAM-1,
PECAM-1 and LFA-1, though, appeared to play an important
role in parasite internalization by inflammatory monocytes. In
vitro studies have shown that hemozoin interferes in the
upregulation of MHC class II and CD54 on monocytes after
IFN-c stimulation [63], altering also their differentiation and
maturation in dendritic cells [64] and antigen presentation [65].
Despite hemozoin is known to impair the ability of monocytes to
repeat phagocytosis [66], no pigment was found when PBMC
were evaluated in our study. Moreover, impairment in phagocy-
tosis was not observed and the monocytes still produced ROS in
response to PMA, in oppose to monocytes previously exposed to
parasitized red blood cells [63]. We believe that phagocytosis of P.
vivax-infected reticulocytes by monocytes are taking place in the
spleen, where bona fide undifferentiated monocytes reside in
equivalent numbers in circulation [67].
Besides their activated phenotype, CD14+ monocytes displayed
an activated morphology with larger mitochondrias. Interestingly,
the CD14+CD16+ subset showed higher mitochondrial activity
than the other monocyte subpopulations. Malaria infection
triggers production of high levels of total ROS. Despite similar
levels of total ROS are produced by different monocyte subsets,
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higher frequencies and levels of intracellular ROS, and higher
expression of p47phox and p67phox were found in CD14+CD16+
cells compared to CD14+CD162 and CD14loCD16+ monocytes.
In addition, staining with MitoSox reveals that CD14+CD16+
monocytes produce higher levels of mitochondrial ROS. ROS are
important effector free radicals involved in Plasmodium killing
[47,68]. Indeed, either blockade of mitochondrial complex I or
blockage of NADPH oxidases, both responsible for ROS
generation, efficiently reduces ROS levels in PBMC and
CD14+CD16+ monocytes from malaria patients. Despite mito-
chondrial ROS have been regarded as byproducts of oxidative
respiration, studies have indicated that mitochondria are recruited
to vacuoles containing pathogens through an active process
mediated by immune signaling [69,70,71]. Moreover, West and
coworkers showed that the reduction of macrophage mitochon-
drial ROS results in defective bacterial killing [71].
Similarly to ROS production, higher frequencies of cells
producing TNF-a, a cytokine known to trigger the respiratory
burst, were found among CD14+CD16+ monocytes exposed to Pv-
Ret. In a different context, patients experiencing severe malarial
anemia triggered by P. falciparum display increased numbers of
circulating monocytes, with significant augment in the numbers of
TNF-a-producing CD14+CD16+ monocytes [72]. It is still unclear
what is the cause of anemia during malaria. Despite recent reports
have shown evidence demonstrating that P. vivax malaria may be
associated with higher frequency and more severe anemia than P.
falciparum, most of these studies were performed with children
already suffering from malnutrition and hospitalized subject
[73,74,75]. Only a small proportion of the P. vivax-infected
patients analyzed in this study presented mild anemia (Table S1)
and their reticulocyte counts are according to the reference values
[76]. In fact, P. vivax infection is responsible for very low
frequencies of infected red blood cells. We believe that during
uncomplicated vivax malaria, phagocytosis of reticulocytes by
monocytes and the production of inflammatory mediators will
preferentially help in the parasite control.
It is important to mention that P. vivax-infected patients display
elevated levels of hepatic biomarkers such as aspartate (AST),
alanine (ALT) aminotransferase and bilirubin. And despite no
correlation was found between monocyte activation markers and
most of the laboratory parameters, such as hematocrit and platelet
counts, higher levels of AST correlated with higher expression of
CCR2 and VCAM-1 on both CD14+CD162 and CD14+CD16+
monocytes and ICAM-1 on CD14+CD162 monocytes (Figure S3).
These data indicate that in the attempt of controlling parasitemia,
monocytes might cause inflammatory damage.
Finally, we observed that CD14loCD16+ patrolling monocytes
from P. vivax malaria patients did not express CCR2 but
expressed high levels of LFA-1 and CX3CR1. The latter two
receptors appear to be responsible for the ability of monocytes to
patrol blood vessels in vivo [18]. Consistent with this hypothesis,
CD16+ monocytes display enhanced capacity to adhere to
endothelial cells in vitro. This ability is partially dependent on
fractalkine, the CX3CR1 ligand and CD11a, the a chain of LFA-1
[77]. Importantly, patrolling monocytes have been shown to
express high levels of TLR8 and TLR9 [18], and may also play an
important role on cytokine production in response to parasite
RNA and DNA. Thus, patrolling monocytes may also contribute
to the early inflammatory response observed during P. vivax
infection.
In conclusion, our findings support the concept that highly
activated monocytes are characteristic of acute malaria. P. vivax-
infection leads to cytokine production by classical and inflamma-
tory monocytes, and this response is likely to be largely responsible
for many of the signs and symptoms observed in malaria sepsis.
Importantly, we demonstrate for the first time that CD14+CD16+
monocytes in malaria patients exhibited greater phagocytic
activity and produced higher levels of intracellular TNF-a and
reactive oxygen species, indicating their important role in parasite
control and host resistance to infection. Further delineation of the
differential roles of monocyte subsets in P. vivax malaria could
lead to identification of specific targets for therapeutic intervention
in this extremely important but highly neglected parasitic disease.
Supporting Information
Figure S1 Size and granularity of human monocyte
subsets. Monocyte subsets are show in a forward scatter area
(FSC-A) versus forward scatter height (FSC-H) dot plot.
CD14+CD162 cells are shown in green, CD14+CD16+ cells in
red and CD14luCD16+ in blue. Other cells from PBMC are shown
in grey.
(EPS)
Figure S2 Apoptosis of monocyte subsets after phago-
cytosis. (A) Proportions of monocyte subsets and (B) frequencies
of Annexin-V expressing CD14+CD162 (green symbols),
CD14+CD16+ (red symbols) and CD14luCD16+ (blue symbols)
monocytes in from P. vivax-infected patients. Cells were culture
for 4 hours with P. vivax-infected reticulocytes (circles), 12 hours
in medium alone (squares) or with P. vivax-infected reticulocytes
(triangles). Symbols represent individual subject. * p,0.05.
(EPS)
Figure S3 Levels of aspartate aminotransferase (AST)
correlate with immunological parameters expressed by
monocytes from P. vivax-infected patients. (A) Levels of
AST before (BT) and after (AT) treatment. Correlation between
AST levels and CCR2, CD54, CD106 expression by
CD14+CD162 (B) or CD14+CD16+ (C) monocytes. The results
are expressed as scattering of individual values. Circles indicate
individual patients (n = 27). Spearman’s rank correlation (r) and p
values are shown in the graphs.
(EPS)
Figure S4 Production of reactive oxygen species during
vivax malaria. Peripheral blood mononuclear cells and purified
monocyte subsets from P. vivax-infected subjects were assessed for
ROS production. (A) The kinetics of ROS production by PBMC
from P. vivax-infected patients evaluated before (BT) and after
treatment (AT) when cells were cultured in medium alone (left
panel) or PMA (right panel) in the presence of luminol measured
by chemiluminescence using Synergy H4 (BioTek) microplate
reader (n = 5). (B) The kinetics of ROS production by sorted
CD14+CD162 (green circles), CD14+CD16+ (red circles) and
CD14luCD16+ (blue circles) from acutely P. vivax-infected
patients cultured in medium alone (top panel), erythrocytes
(RBC, middle panel) or P. vivax-infected reticulocytes (Pv-Ret,
bottom panel) in the presence of carboxy-H2DCFDA measured by
fluorescence using SpectraMax M5 microplate reader (n = 4). (C)
The kinetics of ROS production by PBMC from acutely P. vivax-
infected patients cultured in medium alone (top panel) or PMA
(bottom panel), in the presence of luminol, in the absence or in the
presence of inhibitors of ROS production; rotenone and DPI. Bars
represent mean values and standard error. Results were pooled
from 4 independent experiments. Luminol was measured by
chemiluminescence (n = 5). Statistical analysis were done compar-
ing different treatments over time, **0.05.p.0.01. (D) Mean
fluorescence intensity (MFI) of ROS production was assessed by
flow cytometry in CD14+CD16+ monocytes, among PBMC, from
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P. vivax-infected patients after culture with P. vivax-infected
reticulocytes in the absence or in the presence of rotenone and
DPI. Percentage of inhibition was calculated considering as 100%
the culture in the absence of inhibitors (n = 4). Symbols represent
individual subject. Results are representative of 2 experiments.
(EPS)
Table S1 Study population. Laboratory and clinical records
of Plasmodium vivax-infected patients.
(DOCX)
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